A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus
<i>nab</i>
‐Paclitaxel and Gemcitabine in Advanced Solid Tumors

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab ‐Paclitaxel and Gemcitabine in Advanced Solid Tumors

Beatty, Gregory L.; Shahda, Safi; Beck, Thaddeus; Uppal, Nikhil; Cohen, Steven J.; Donehower, Ross; Gabayan, Afshin Eli; Assad, Albert; Switzky, Julie; Zhen, Huiling; Von Hoff, Daniel D.

期刊名称The Oncologist
作者Beatty, Gregory L.; Shahda, Safi; Beck, Thaddeus; Uppal, Nikhil; Cohen, Steven J.; Donehower, Ross; Gabayan, Afshin Eli; Assad, Albert; Switzky, Julie; Zhen, Huiling; Von Hoff, Daniel D.
印刷ISSN1083-7159
电子ISSN1549-490X
文件大小781.82KB
发表时间2018-08-16
DOI10.1634/theoncologist.2017-0665

发现好书期刊，享受阅读乐趣

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab ‐Paclitaxel and Gemcitabine in Advanced Solid Tumors